Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Cyclopentanohydrophenanthrene ring system doai
Reexamination Certificate
2006-02-28
2006-02-28
Wang, Shengjun (Department: 1617)
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Cyclopentanohydrophenanthrene ring system doai
C514S177000, C514S182000, C514S169000, C514S320000, C514S319000, C514S470000, C514S469000
Reexamination Certificate
active
07005428
ABSTRACT:
Novel methods for the medical treatment and/or inhibition of the development of hypercholesterolemia in susceptible warm-blooded animals including humans involving administration of selective estrogen receptor modulator particularly compounds having the general structure:and an amount of a sex steroid precursor selected from the group consisting of dehydroepiandrosterone, dehydroepiandrosterone sulfate, androst-5-ene-3β,17β-diol and compounds converted in vivo to one of the foregoing precursor. Further administration of bisphosphonates in combination with selective estrogen receptor modulators and/or sex steroid precursor is disclosed for the medical treatment and/or inhibition of the development of osteoporosis. Pharmaceutical compositions for delivery of active ingredient(s) and kit(s) useful to the invention are also disclosed.
REFERENCES:
patent: 5407947 (1995-04-01), Bryant et al.
patent: 5446071 (1995-08-01), Grese
patent: 5830887 (1998-11-01), Kelly
patent: 5840735 (1998-11-01), Labrie et al.
patent: 5843984 (1998-12-01), Clay et al.
patent: 0 747 056 (1996-12-01), None
patent: 0781555 (1997-07-01), None
patent: P99002847 (1992-07-01), None
patent: 208150 (1993-08-01), None
patent: P9500229 (1996-05-01), None
patent: P9501985 (1996-07-01), None
patent: P9801230 (1999-06-01), None
patent: WO9310741 (1993-06-01), None
patent: WO9959581 (1999-11-01), None
Sharma et al. “Structure-activity of antiestrogens. Phenolic analogues of 2,3-Diaryl-2H-1-benzopyrans,” 1990, J. Med. Chem. 33, p. 3222-3229.
CAPLUS Abstract, AN 1967:505730, Ben-David et al., 1967.
CAPLUS Abstract, AN 1994:479820, Wojtacki et al. 1994.
Calin Chen et al., “Adrenal Steroid Precursors Exert Potent Androgenic Action in the Hamster Sebaceous Glands of Flank Organs and Ears”,Endocrinology137:1752-1757, 1996.
Claude Labrie et al., “Stimulation of Androgen-Dependent Gene Expression by the Andrenal Precursors Dehydroepiandrosterone and Androstenedione in the Rat Ventral Prostate”,Endocrinology124:2745-2754, 1989.
Claude Labrie et al., “Androgenic Activity of Dehydroepiandrosterone and Androstenedione in the Rat Ventral Prostate”,Endocrinology123: 1412-1417, 1988.
Delmas et al.,N. Engl. J. Med., Dec. 4, 1997; vol. 337(23), pp. 1641-1647.
N. Engl. J. Med.1998, vol. 319, pp. 1681-1692.
F. Labrie et al., “DHEA and the Intracrine Formation of Androgens and Estrogens in Peripheral Target Tissues: Its Role During Aging,” Steroids, 53:322-328 (1998).
F. Labrie et al., “Interactions Between Estrogens, Androgens, Progestins, and Glucocorticoids in ZR-75-1 Human Breast Cancer Cells,” Annals New York Academy of Sciences, pp. 130-148, 1990.
S. Luo et al., “Prevention of Development of Dimethylbenz(a)anthracene (DMBA)—Induced Mammary Tumors in the Rat by the New Nonsteroidal antiestrogen EM-800 (SCH57050),” Breast Cancer Research and Treatment 49:1-11 (1998).
Couillard, S.; Labrie, C.; Gauthier, S.; Labrie, F., Abstract,Maturitas, (1997), vol. 27, No. SUPPL., pp. 80, Title: “Inhubitory Effect of a new Non-Steroidal Pure Antiestrogen (EM-800) in Combination with DHEA on Human ZR-75-1 Breast Tumors in Nude Mice”.
Merck Index, 11thEd., nos. 0\9010 and 9474.
Derwent abstract of JP 10036347.
Derwent abstract of WO 97/25034.
Endorecherche Inc.
Ostrolenk Faber Gerb & Soffen, LLP
Wang Shengjun
LandOfFree
Medical uses of a selective estrogen receptor modulator in... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Medical uses of a selective estrogen receptor modulator in..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Medical uses of a selective estrogen receptor modulator in... will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-3627400